Document is current
Any future updates will be listed below
-
Authors
Xiang, Yulan
Li, Zelu
He, Xin
Chu, Xiaoyang
Gao, Chunyan
Guo, Jiahao
Luan, Yingyi
Yang, Kai
Zhang, Dongliang
-
Funding
Funding for this research was provided by:
the China Higher Education Innovation Fund (2024GR056)
the Capital's Funds for Health Improvement and Research (2024-2-2143)
Beijing Nova Program (Nos20230484404)
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 22 April 2025
First Online: 1 May 2025
Declarations
:
: This experiment was approved by the Animal Welfare Ethics Committee of Beijing MDKN Biotechnology Co., LTD.(Approval number: MDKN-2023-048; Date of approval: 2022.3.25;Title of the approved project: “Puerarin relives inflammation, bone destruction and facilitates osteogenic differentiation in periodontitis by enhancing mitochondrial autophagy via activating mitochondrial Mitofusin 2”), and was conducted in strict accordance with the experimental animal care and use guidelines of Beijing Animal Control Committee. The original source of hPDLCs (Procell Life Science & Technology, Wuhan, China) () has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent.
: All authors confirm their consent for publication.
: All authors declare that they have no competing interests.
